Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.
Pellini Discusses Immunotherapies and Current Limitations of ctDNA in Perioperative NSCLC
Lunning and Rutherford Detail Considerations for BV-AVD Use in Older Patients With Hodgkin Lymphoma
Melanoma In Darker Skin Tones: Race and Sex Play A Role, Mayo Study Finds
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
Ongoing Research Aims to Expand Treatment Options, Address Unmet Needs in GVHD
EV-302 Trial Ushers in Era of Novel Combos in First-Line Metastatic Urothelial Cancer
Dr Liu Previews ASCO 2024 Lung Cancer Data
Dr Rajkumar Previews ASCO 2024 Data in Multiple Myeloma
Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer